Parallel study as pilot for long half life drug [Design Issues]

posted by jag009  – NJ, 2012-05-07 17:13 (5147 d 13:52 ago) – Posting: # 8524
Views: 6,587

Hi everyone,

I am working on a drug with a half life of 100-120 hrs :angry: and so far I haven't been able to get any information about its intrasubject CV. Due to timing issues, I am considering running a pilot parallel study to compare a prototype generic against the innovator.

Question. If I proceed with this, does that mean I will have to conduct my pivotal studies as parallel studies since the CV I get from the pilot is the total CV?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
215 visitors (0 registered, 215 guests [including 15 identified bots]).
Forum time: 07:06 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5